Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial

Stem Cells ◽

Mesenchymal Stem Cells ◽

Controlled Trial ◽

Double Blind ◽

Wharton's Jelly ◽

Randomized Controlled ◽

Intracoronary Infusion

Umbilical cord mesenchymal stem cells for COVID ‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial

Stem Cells Translational Medicine ◽

10.1002/sctm.20-0472 ◽

2021 ◽

Author(s):

Giacomo Lanzoni ◽

Elina Linetsky ◽

Diego Correa ◽

Shari Messinger Cayetano ◽

Roger A. Alvarez ◽

...

Keyword(s):

Stem Cells ◽

Mesenchymal Stem Cells ◽

Acute Respiratory Distress Syndrome ◽

Respiratory Distress Syndrome ◽

Distress Syndrome ◽

Controlled Trial ◽

Phase 1 ◽

Double Blind ◽

Umbilical Cord Mesenchymal Stem Cells for COVID-19 ARDS: A Double Blind, Phase 1/2a, Randomized Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3696875 ◽

2020 ◽

Author(s):

Giacomo Lanzoni ◽

Elina Linetsky ◽

Diego Correa ◽

Shari Messinger Cayetano ◽

Antonio C. Marttos ◽

...

Keyword(s):

Stem Cells ◽

Mesenchymal Stem Cells ◽

Umbilical Cord ◽

Controlled Trial ◽

Phase 1 ◽

Double Blind ◽

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13409136.14780164 ◽

2011 ◽

Author(s):

John Laffey ◽

Mairead Hayes

Keyword(s):

Myocardial Infarction ◽

Stem Cells ◽

Mesenchymal Stem Cells ◽

Dose Escalation ◽

Human Mesenchymal Stem Cells ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Adult Human

Therapy for replenishing qi, nourishing yin and promoting blood circu-lation in patients with acute myocardial infarction undergoing percu-taneous coronary intervention: a randomized controlled trial

Journal of Chinese Integrative Medicine ◽

10.3736/jcim20090704 ◽

2009 ◽

Vol 7 (7) ◽

pp. 616-621 ◽

Cited By ~ 5

Author(s):

SL Qiu

Keyword(s):

Myocardial Infarction ◽

Controlled Trial ◽

Coronary Intervention ◽

Randomized Controlled ◽

Nourishing Yin

SAFETY AND EFFICACY OF DPP4 INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: A BIOMARKER DRIVEN DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01417-0 ◽

2021 ◽

Vol 77 (18) ◽

pp. 58

Author(s):

Paulo Rizzo Genestreti ◽

Remo Furtado ◽

Rocío Salsoso ◽

Talia Dalcoquio ◽

Carlos Nakashima ◽

...

Keyword(s):

Myocardial Infarction ◽

Controlled Trial ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Dpp4 Inhibitors ◽

Double Blinded

1400: Evaluating the effect of a combined reactive and proactive telephone follow-up intervention after acute myocardial infarction. A randomized controlled trial.

European Journal of Cardiovascular Nursing ◽

10.1177/14745151060050s185 ◽

2006 ◽

Vol 5 (1_suppl) ◽

pp. 46-46 ◽

Cited By ~ 3

Author(s):

T.A. Hanssen ◽

J.E. Nordrehaug ◽

G.E. Eide ◽

B.R. Hanestad

Keyword(s):

Myocardial Infarction ◽

Controlled Trial ◽

Effect of Erythropoietin Administration on Myocardial Viability and Coronary Microvascular Dysfunction in Anterior Acute Myocardial Infarction: Randomized Controlled Trial in the Japanese Population

Cardiology and Therapy ◽

10.1007/s40119-018-0122-1 ◽

2018 ◽

Vol 7 (2) ◽

pp. 151-162 ◽

Cited By ~ 1

Author(s):

Makoto Orii ◽

Kumiko Hirata ◽

Kazushi Takemoto ◽

Takashi Akasaka

Keyword(s):

Myocardial Infarction ◽

Myocardial Viability ◽

Japanese Population ◽

Controlled Trial ◽

Microvascular Dysfunction ◽

Coronary Microvascular Dysfunction ◽

Response to Letter Regarding Article “Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial”

Circulation Cardiovascular Interventions ◽

10.1161/circinterventions.109.915942 ◽

2009 ◽

Vol 2 (6) ◽

Author(s):

Marieke L. Fokkema ◽

Pieter J. Vlaar ◽

Felix Zijlstra

Keyword(s):

Myocardial Infarction ◽

Percutaneous Coronary Intervention ◽

Controlled Trial ◽

Coronary Intervention ◽

High Dose ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Adenosine Administration

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

Yearbook of Cardiology ◽

10.1016/s0145-4145(10)79814-2 ◽

2010 ◽

Vol 2010 ◽

pp. 389-391 ◽

Cited By ~ 3

Author(s):

B.J. Gersh

Keyword(s):

Myocardial Infarction ◽

Stem Cells ◽

Mesenchymal Stem Cells ◽

Dose Escalation ◽

Human Mesenchymal Stem Cells ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Adult Human

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

Journal of Translational Medicine ◽

10.1186/s12967-018-1422-x ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 22

Author(s):

Qipeng Sun ◽

Zhengyu Huang ◽

Fei Han ◽

Ming Zhao ◽

Ronghua Cao ◽

...

Keyword(s):

Stem Cells ◽

Multicenter Randomized Controlled Trial

Mesenchymal Stem Cells ◽

Induction Therapy ◽

Controlled Trial ◽

Renal Allografts ◽

Randomized Controlled ◽